Last year, scientists have made significant progress in making the production of induced pluripotent cells either safe or efficient. However, experts warn of fundamental problems with applying stem cell products to patients. Thus, the advent of replacement organs grown in the lab is still years away.
Read my story in today's issue of Current Biology:
Stem cell moves
Current Biology, Volume 20, Issue 1, R3-R4, 12 January 2010
Progress with both embryonal and induced pluripotent stem cells is bringing clinical applications a step closer.
summary and limited access to pdf file
1 comment:
I find that for stem cell research we should have more openness in testing and funds availability to the organizations. Stem cell treatments are going play a major role and change way of medical sciences in the near future.
Post a Comment